ENRIQUE
CASADO SAENZ
PROFESOR DOCTOR
![Foto de Jaime](/img/nophoto.png)
Jaime
Feliu Batlle
Publicacions en què col·labora amb Jaime Feliu Batlle (45)
2017
2015
-
Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancer
PLoS ONE, Vol. 10, Núm. 1
-
Gene expression differences in primary colorectal tumors and matched liver metastases: chemotherapy related or tumoral heterogeneity?
Clinical and Translational Oncology, Vol. 17, Núm. 4, pp. 322-329
-
SMAD4 and TS expression might predict the risk of recurrence after resection of colorectal liver metastases
Clinical and Translational Oncology, Vol. 17, Núm. 2, pp. 133-138
2014
-
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study
British Journal of Cancer, Vol. 111, Núm. 2, pp. 241-248
2013
-
SEOM Clinical guidelines for the treatment of advanced colorectal cancer 2013
Clinical and Translational Oncology, Vol. 15, Núm. 12, pp. 996-1003
2012
-
Expression profile as predictor of relapse after adjuvant treatment in gastric cancer
Journal of Gastrointestinal Cancer, Vol. 43, Núm. 2, pp. 181-189
-
Internet use by cancer patients: Should oncologists 'prescribe' accurate web sites in combination with chemotherapy? A survey in a spanish cohort
Annals of Oncology, Vol. 23, Núm. 6, pp. 1579-1585
-
Management of colorectal cancer patients after resection of liver metastases: Can we offer a tailored treatment?
Clinical and Translational Oncology, Vol. 14, Núm. 9, pp. 641-658
-
Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target
International Journal of Radiation Oncology Biology Physics, Vol. 84, Núm. 5, pp. 1151-1158
2011
-
A combined strategy of SAGE and quantitative PCR provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancer
Clinical Cancer Research, Vol. 17, Núm. 12, pp. 4145-4154
2009
-
Chemotherapy for colorectal cancer in the elderly: Whom to treat and what to use
Cancer Treatment Reviews, Vol. 35, Núm. 3, pp. 246-254
-
Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: Multicenter phase II study
Cancer Chemotherapy and Pharmacology, Vol. 63, Núm. 3, pp. 403-409
-
EPO-R expression patterns in resected gastric adenocarcinoma followed by adjuvant chemoradiation treatment
Pathology and Oncology Research, Vol. 15, Núm. 1, pp. 1-10
-
KRAS mutations in primary colorectal cancer tumors and related metastases: A potential role in prediction of lung metastasis
PLoS ONE, Vol. 4, Núm. 12
-
Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy
International Journal of Colorectal Disease, Vol. 24, Núm. 7, pp. 741-748
2008
-
Cardiac toxicity: Old and new issues in anti-cancer drugs
Clinical and Translational Oncology, Vol. 10, Núm. 1, pp. 35-46
-
EGFR and colon cancer: A clinical view
Clinical and Translational Oncology, Vol. 10, Núm. 1, pp. 6-13
-
Idiopathic and recurrent thromboembolic phenomena in cancer patients
Clinical and Translational Oncology, Vol. 10, Núm. 10, pp. 665-669
-
Internet use for medical research among cancer patients and their relatives in Spain
Annals of Oncology